These are all common and important considerations
The series, authored by RWJF Senior Policy Adviser Katherine Hempstead, analyzes changes in the individual market
For full clinical data, see our GLP-1 weight loss guide
Retatrutide may be available as a research peptide, but that is not the same as an approved personal treatment
Retatrutide goes further by adding glucagon receptor activation to the mix, creating a synergistic effect that produces greater metabolic changes than either dual or single agonists alone
This initiative has the potential to make a lasting impact in our communities by providing more reliable, consistent access to these life-changing medications for the millions of Americans who want a better, more affordable way to take care of their health." According to the World Health Organization (WHO), around 70% of American adults have obesity or are overweight and at least 2.8 million people die each year due to being overweight or having obesity